Evaluation of desmoglein enzyme‐linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris
Authors:
- 27 April 2006
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 45 (5) , 518-522
Abstract
To evaluate the role of the enzyme-linked immunosorbent assay (ELISA) test for the detection of antibodies to desmoglein 1 (dsg1) and desmoglein 3 (dsg3) in the diagnosis of pemphigus vulgaris (PV), and its correlation with disease severity and clinical presentation (mucosal PV, cutaneous PV, mucocutaneous PV). Twenty-seven active PV patients and 26 controls with other dermatologic disorders were included in the study. The severity of oral and cutaneous involvement was assessed and recorded. ELISA test for the measurement of anti-dsg1 and anti-dsg3 antibodies was performed (Medical and Biological Laboratories Co. Ltd., Nagoya, Japan). The cut-off ELISA value for both anti-dsg1 and anti-dsg3 was taken as 20. Of the 27 patients, 26 were ELISA positive for anti-dsg1 antibodies and 23 for anti-dsg3 antibodies. Of the controls, two were positive for anti-dsg1 and none for anti-dsg3 antibodies. The sensitivity and specificity of ELISA for anti-dsg1 in the diagnosis of PV were 96.3% and 92.3%, respectively. For anti-dsg3, they were 85.2% and 100%, respectively. The different morphologic types of PV could not be differentiated on the basis of antibody profile; however, a direct correlation between anti-dsg3 titers and the severity of oral disease was noted, and also between anti-dsg1 titers and the severity of cutaneous disease. ELISA (dsg1 and dsg3) is an efficient tool for confirming the diagnosis of PV. Specific antibody titers correlate with disease severity; however, desmoglein testing cannot differentiate between the various morphologic subtypes of PV.Keywords
This publication has 13 references indexed in Scilit:
- Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgarisJournal of the American Academy of Dermatology, 2003
- A Subset of Pemphigus Foliaceus Patients Exhibits Pathogenic Autoantibodies Against Both Desmoglein-1 and Desmoglein-3Journal of Investigative Dermatology, 2002
- The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levelsBritish Journal of Dermatology, 2001
- A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotypeBritish Journal of Dermatology, 2000
- Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3Clinical and Experimental Dermatology, 2000
- Desmoglein 3-ELISAArchives of Dermatology, 1999
- Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigusBritish Journal of Dermatology, 1999
- Use of recombinant pemphigus vulgaris antigen in development of ELISA and IB assays to detect pemphigus vulgaris autoantibodiesJournal of the European Academy of Dermatology and Venereology, 1998
- Use of recombinant pemphigus vulgaris antigen in development of ELISA and IB assays to detect pemphigus vulgaris autoantibodiesJournal of the European Academy of Dermatology and Venereology, 1998
- Mucosal and Mucocutaneous (Generalized) Pemphigus Vulgaris Show Distinct Autoantibody ProfilesJournal of Investigative Dermatology, 1997